10 million people in India are obese victims, increased diabetes, hypertension and heart disease … will the treatment be cheaper? Learn

There are about half of adults in India growing towards becoming the superpower of the world, who reduce physical labor than need. The reason for this is the changing lifestyle and the changing habits of food from above. The result of this is that about 10 crore people in India have been surrounded by obesity. According to a research, according to a research, by 2050, about 44 crore people in India will be surrounded by obesity. If obesity comes, it brings every kind of disease with you, whether it is diabetes, hypertension or heart disease. Even the risk of many types of cancer increases due to this.

This is the reason that Prime Minister Modi himself insists on exercising or using edible oil to avoid obesity from people. Prime Minister Modi himself is also very aware of fitness. Yoga and restrained catering is an essential part of their routine. His awareness about fitness is that he does not back down in taking fitness challenge and also in giving fitness challenge. This can also be a very effective way to make the people of the country aware of health, but crores of people of India, who have come under the imprisonment of the changing lifestyle and the imprisonment of mobile phones, are still not able to realize this crisis of obesity. The best way to deal with this is yoga, exercise, walking or restrained food, but if the merge increases then the medicine is required.

But medicines come with a price. After paying the price of health due to negligence, people also have to pay the price of medicines. To deal with this, the government has launched an effective campaign Pradhan Mantri Jan Aushadhi Yojana. Under this, generic medicines are provided at cheap prices equivalent for branded medicines.

Important information for diabetes patients

Actually, the price of Empagliflozin, an effective diabetes drug in India, is going to be reduced by 90%. Many pharmaceutical companies in India have prepared to make a generic medicine of diabetes. The reason for this is that the patent of this diabetes drug is over on March 10. After the patent is over, the period of ban on making this medicine by someone else will end. In such a situation, many Indian pharmaceutical companies like Torrent, Alchem, Dr. Reddy and Lupin are planning to launch this drug version in the market soon. This is likely to reduce the price of a tablet of 60 rupees for this diabetes medicine to remain between 9 and 14 rupees. This will also affect the market for diabetes medicines in India, which is worth about 20 thousand crores today.

According to the International Diabels Federation, more than 10 crore people in India are victims of diabetes and they take a lot of money in the medicine of this disease. They will definitely get some relief due to decrease in the price of new diabetes medicine.

By the way, efforts are made to give relief to the public by reducing the prices of medicines. In May last year, the government had reduced the prices of 41 drugs used in problems like diabetes, heart and liver diseases. Efforts are also made to control the cost of medicines. Last year, Department of Pharmaceuticals and National Pharmaceutical Pricing Authority had fixed the sub -prices of 923 drugs from 1 April 2024. That is, those medicines cannot be sold more than that price.

Pradhan Mantri Jan Aushadhi Yojana

The Prime Minister of India is very popular to make medicines economical and to reach the public’s access to pockets. This scheme was launched in 2008 by the Ministry of Chemicals and Fertilizers in the name of Jan Aushadhi Yojana. In 2016, its name was changed to the Prime Minister’s Bharatiya Jan Aushadhi Project. Under this, people are provided at affordable prices equivalent to branded medicines. In this connection, 7 March is celebrated as Jan Aushadhi Day every year to spread awareness.

Under this scheme, Jan Aushadhi centers have been opened across the country, where quality generic medicines are made available at affordable prices. There was no enthusiasm about this scheme till 2015. By then, only 80 Jan Aushadhi centers were open in the selected states, but since 2016, there was a huge rise in it. In 2016-17, there were 1080 Jan Aushadhi centers and after that it caught so fast that by March this year, more than 15 thousand Janushadhi centers have opened across the country. From where you can take generic medicines at a cheaper price.

What are these generic medicines

There will now be few people in the country who will not know about generic drugs. Not only India, in most countries of the world, generic medicines are sold by the intervention of governments so that people can get cheap medicines. Therefore, we can call generic drugs an affordable version of branded drugs. Generic drugs are launched in the market when the duration of the original drug manufacturer’s patent is over. As we told you above, the patent of an effective drug Empagliflozin of diabetes is ending. After this, the way to make its generic medicine will open.

Potency of generic medicines means effectiveness, quality and their effects do not decrease, that is, it affects the body in the same way as branded medicines. These generic medicines are either sold in the name of their salt or from any other brand name. The work of making medicines in India has reached so much that today India is called the pharmacy of the world. During the Kovid epidemic, India had made a big approval by transporting the vaccine of Kovid to many countries of the world. India’s pharma industry has its own identity in the world to prepare life -saving medicines at affordable cost.

There are about 3 thousand pharma companies in India which have 10 thousand 500 production units. So this is a picture of the entire pharma industry. But we are especially talking about generic medicines whose needs are increasing day by day and now they are more available for the common people than ever.

Story of generic medicines reaching here in India

At the time of independence, foreign companies were mainly dominated by India’s pharmaceutical industry. At that time, 90 percent of the drug markets in India were controlled by American and European companies. In the sixties, the Government of India started promoting indigenous pharmaceutical companies in the pharma sector but the target could not be achieved by the seventies.

In the seventies, the then Indira Gandhi government implemented a law under which the government banned the patent of medical products in the country. From the Patent Act 1970, it happened that instead of medical products, the process of making medicines was allowed to patent. That is, the patent on the medicine was removed, the patent remained on the process of its construction.

This led to a revolutionary change in the Indian pharmaceutical industry. After this, Indian pharmaceutical companies got the right to make medicines like branded medicines of any other company in the country, provided the process of making those medicines is second. That is, the patent remained on the process, the product was removed. After this, Indian companies studied the medicine and prepared their process of preparing it. Identified the material used in their manufacture and then changed the original process and prepared the same medicine at a very low cost. And did not violate the process patent either.

After this, the Indian pharma sector increased rapidly. Between the seventies to the eighties, companies in the Indian Pharma sector doubled. Along with this, Indian pharmaceutical companies also intensified their research, as a result of this, after the arrival of a medicine in the world market, the same medicine started to become in India in a very short time, but through a separate process. Earlier, this work used to take a long time. According to many reports, by 2006, Indian pharma companies started preparing 95 percent of the need for drugs in the country themselves, but there were some shortcomings in this whole work too. Indian companies used to get less margin on their products, due to which they were not saving much money for research and development and research and development. It changed by India’s signing of an agreement in 1995.

Trips agreement of 1995

Apart from this success of generic drugs, there is another aspect that there have been complaints about generic drugs. For example, in 2018, Central Drug Standard Control Organization (CDSCO) identified 4.5% of the total generic drugs that were poor quality ie were substandard. One of the major reasons for this is lack of quality testing facilities in the country. Corruption from above. According to IMA, only 0.1% of the drugs made in the country are tested for quality.

Institutions that keep an eye on the quality and construction of medicines also have a reason for money, resources and manpower. Apart from this, even those who make fake medicines have not been completely controlled. Such fake drug suppliers work at the level of drug dealers. Many times they sell their fake medicines in the name of a big company, while the original company does not know it but generic medicines are still a big relief for the people.